CIBC World Market
AVXL icon

CIBC World Market’s Anavex Life Sciences AVXL Stock Holding History

CIBC World Market’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,187
Closed -$60K – 1306
2024
Q2 		$60K Sell
14,187
-625
-4% -$2.53K ﹤0.01% 1232
2024
Q1 		$75K Sell
14,812
-485
-3% -$2.73K ﹤0.01% 1258
2023
Q4 		$142K Sell
15,297
-496
-3% -$3.42K ﹤0.01% 1189
2023
Q3 		$103K Sell
15,793
-62
-0.4% -$493 ﹤0.01% 1181
2023
Q2 		$129K Sell
15,855
-183
-1% -$1.57K ﹤0.01% 1157
2023
Q1 		$137K Sell
16,038
-145
-0.9% -$1.45K ﹤0.01% 1175
2022
Q4 		$150K Sell
16,183
-136
-0.8% -$1.45K ﹤0.01% 1183
2022
Q3 		$168K Sell
16,319
-154
-0.9% -$1.63K ﹤0.01% 1145
2022
Q2 		$165K Buy
16,473
+123
+0.8% +$1.17K ﹤0.01% 1172
2022
Q1 		$201K Buy
16,350
+96
+0.6% +$1.18K ﹤0.01% 1211
2021
Q4 		$282K Buy
16,254
+517
+3% +$9.82K ﹤0.01% 1147
2021
Q3 		$282K Buy
+15,737
New +$313K ﹤0.01% 1145

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CIBC World Market's AVXL Position: Q3 2024 in Review

CIBC World Market sold out of Anavex Life Sciences (AVXL) in Q3 2024, closing a stake of 14,187 shares — an estimated $60K sold.

CIBC World Market first reported a position in AVXL in Q3 2021 and held it in 12 quarters. The position peaked at $282K in Q4 2021. 145 funds tracked by Wall St. Rank hold AVXL as of Q3 2024.

  • CIBC World Market reported no remaining Anavex Life Sciences position as of Q3 2024 after selling out during the quarter.
  • CIBC World Market sold 14,187 Anavex Life Sciences shares in Q3 2024, an estimated $60K.
  • CIBC World Market first reported a position in Anavex Life Sciences in Q3 2021 and held it in 12 quarters.
  • CIBC World Market's Anavex Life Sciences position peaked at $282K in Q4 2021.
  • 145 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2024.

Based on CIBC World Market's 13F filing for Q3 2024, filed 12 Nov 2024.